(NYSE: ABT) Abbott Laboratories's forecast annual revenue growth rate of 6.71% is not forecast to beat the US Medical Devices industry's average forecast revenue growth rate of 8.24%, and while it is not forecast to beat the US market's average forecast revenue growth rate of 10.4%.
Abbott Laboratories's revenue in 2025 is $42,344,000,000.On average, 9 Wall Street analysts forecast ABT's revenue for 2025 to be $77,775,780,746,997, with the lowest ABT revenue forecast at $77,507,626,711,992, and the highest ABT revenue forecast at $78,079,615,348,225. On average, 9 Wall Street analysts forecast ABT's revenue for 2026 to be $83,701,865,567,817, with the lowest ABT revenue forecast at $83,110,719,592,267, and the highest ABT revenue forecast at $84,380,328,716,035.
In 2027, ABT is forecast to generate $89,490,708,608,604 in revenue, with the lowest revenue forecast at $88,342,649,679,791 and the highest revenue forecast at $90,375,805,174,425.